For example, upregulation of the H2AK15 E3 ubiquitin ligase RNF168 is critical for the resistance of cancer cells to endogenous or treatment-induced proteotoxic stress [95] and, therefore, RNF168 may be a promising target for a therapeutic strategy exploiting aberrant histone ubiquitination in cancers. This evidence concerns the gene RNF168 and cancer.